Colony Group LLC Moderna, Inc. Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Colony Group LLC holds 22,889 shares of MRNA stock, worth $779,599. This represents 0.04% of its overall portfolio holdings.

Number of Shares

22,889

Previous 21,564 6.14%

Holding current value

$779,599

Previous $2.62 Million 9.77%

% of portfolio

0.04%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $127,743 - $167,758	1,325 Added 6.14%	22,889 $2.36 Million
Q2 2023 Aug 15, 2023	BUY	$118.5 - $160.53 $376,119 - $509,522	3,174 Added 17.26%	21,564 $2.62 Million
Q1 2023 May 16, 2023	BUY	$135.66 - $197.02 $1.23 Million - $1.78 Million	9,051 Added 96.92%	18,390 $2.82 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $1.11 Million - $1.96 Million	9,339 New	9,339 $1.68 Million
Q2 2022 Aug 16, 2022	SELL	$117.13 - $176.59 $158,125 - $238,396	-1,350 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $79,037 - $146,906	-625 Reduced 31.65%	1,350 $233,000
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $169,365 - $276,382	750 Added 61.22%	1,975 $502,000
Q3 2021 Nov 17, 2021	SELL	$221.9 - $484.47 $335,069 - $731,549	-1,510 Reduced 55.21%	1,225 $471,000
Q2 2021 Aug 18, 2021	BUY	$129.91 - $234.98 $39,882 - $72,138	307 Added 12.64%	2,735 $643,000
Q1 2021 May 21, 2021	SELL	$109.18 - $185.98 $70,093 - $119,399	-642 Reduced 20.91%	2,428 $318,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $201,821 - $521,470	3,070 New	3,070 $321,000

Others Institutions Holding MRNA

# of Institutions

940

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account